1. Home
  2. SCLX vs NHTC Comparison

SCLX vs NHTC Comparison

Compare SCLX & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • NHTC
  • Stock Information
  • Founded
  • SCLX 2011
  • NHTC 1988
  • Country
  • SCLX United States
  • NHTC United States
  • Employees
  • SCLX N/A
  • NHTC N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • SCLX Health Care
  • NHTC Miscellaneous
  • Exchange
  • SCLX Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • SCLX 51.3M
  • NHTC 59.2M
  • IPO Year
  • SCLX N/A
  • NHTC 1995
  • Fundamental
  • Price
  • SCLX $0.23
  • NHTC $5.14
  • Analyst Decision
  • SCLX Strong Buy
  • NHTC
  • Analyst Count
  • SCLX 4
  • NHTC 0
  • Target Price
  • SCLX $14.00
  • NHTC N/A
  • AVG Volume (30 Days)
  • SCLX 1.1M
  • NHTC 11.4K
  • Earning Date
  • SCLX 05-12-2025
  • NHTC 04-30-2025
  • Dividend Yield
  • SCLX N/A
  • NHTC 15.69%
  • EPS Growth
  • SCLX N/A
  • NHTC 0.43
  • EPS
  • SCLX N/A
  • NHTC 0.05
  • Revenue
  • SCLX $55,152,000.00
  • NHTC $42,963,000.00
  • Revenue This Year
  • SCLX $24.19
  • NHTC N/A
  • Revenue Next Year
  • SCLX $109.90
  • NHTC N/A
  • P/E Ratio
  • SCLX N/A
  • NHTC $100.44
  • Revenue Growth
  • SCLX 22.02
  • NHTC N/A
  • 52 Week Low
  • SCLX $0.21
  • NHTC $4.02
  • 52 Week High
  • SCLX $2.30
  • NHTC $7.40
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 36.43
  • NHTC 49.44
  • Support Level
  • SCLX $0.22
  • NHTC $5.02
  • Resistance Level
  • SCLX $0.29
  • NHTC $5.18
  • Average True Range (ATR)
  • SCLX 0.03
  • NHTC 0.12
  • MACD
  • SCLX -0.00
  • NHTC -0.01
  • Stochastic Oscillator
  • SCLX 25.59
  • NHTC 15.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: